Roche wins Japan approval for personalised cancer drug Rozlytrek

18 June 2019 - Swiss drugmaker Roche’s push into personalised cancer medicines hit a milestone on Tuesday with Japanese approval ...

Read more →

Extremely high drug prices should be reviewed for appropriateness

21 May 2019 - As medicine advances, a succession of highly efficacious but extremely costly therapeutic drugs have arrived on ...

Read more →

Novartis gets approval to sell Kymriah in Japan for $306,000

15 May 2019 - A Japanese government panel approved on Wednesday a price of 33.5 million yen ($305,800) for Novartis’ cancer ...

Read more →

Japan health ministry orders Ono Pharmaceutical to add warning to Opdivo cancer drug after death

10 May 2019 - The health ministry said Thursday that a patient taking the cancer drug Opdivo has died and ...

Read more →

Daiichi Sankyo’s EZH1/2 dual inhibitor valemetostat (DS-3201) receives SAKIGAKE designation for treatment of patients with relapsed/refractory peripheral T-cell lymphoma from Japan MHLW

9 April 2019 - SAKIGAKE designation will provide development support and accelerated review of valemetostat, an investigational and potential first-in-class EZH1/2 ...

Read more →

AbbVie announces first regulatory approval of Skyrizi (risankizumab) for the treatment of plaque psoriasis, generalised pustular psoriasis and erythrodermic psoriasis and psoriatic arthritis in Japan

26 March 2019 - This marks the first regulatory approval globally for SKYRIZI™ (risankizumab). ...

Read more →

Exploring the application of cost-effectiveness evaluation in the Japanese National Health Insurance System

21 March 2019 - Japan's Central Social Insurance Medical Council (“Chuikyo”) began in 2012 to examine how cost-effectiveness evaluation might ...

Read more →

Japan approves two gene treatments in bid to catch up

21 February 2019 - Potential revolutionary treatments have exorbitant price tags. ...

Read more →

As medical costs mount, Japan to weigh cost-effectiveness in setting drug prices

18 February 2019 - Japanese doctor Yasushi Goto remembers prescribing the cancer drug Opdivo to an octogenarian and wondering whether ...

Read more →

MAESTrO Database on exhibit at ISPOR Asia-Pacific Conference

12 August 2018 - Exciting new features to be launched at the conference. ...

Read more →

EU and Japan reinforce their collaboration on inspections of medicine manufacturers

18 July 2018 - Update of 2004 mutual recognition agreement extends scope to sterile products, active pharmaceutical ingredients and biologicals ...

Read more →

FDA faster than global peers at approving new drugs

16 May 2018 - A report from the Centre for Innovation in Regulatory Science released this month finds that the ...

Read more →

Ohara cuts price of generic drug for leukaemia

11 April 2018 - Ohara Pharmaceutical Co. has reduced the price of its generic drug for leukaemia to about half ...

Read more →

Government to cut price of Opdivo by over 20%

5 March 2018 - Japan’s health ministry said Monday that the government-set price of cancer drug Opdivo will be reduced ...

Read more →

Looming tipping point for Japan pharma

15 December 2017 - Changes to Japan’s drug reimbursement system care are inevitable. The only questions are the extent of ...

Read more →